Tesamorelin
Also known as Egrifta
Tesamorelin is an approved injectable that boosts your own growth hormone and is used specifically to reduce deep belly (visceral) fat.
How one dose clears
modeled over ~6 half-lives- Half-life
- 30 min
- Time to peak (Tmax)
- 15 min
- Typical dose
- 2 mg
GHRH analog FDA-approved to reduce visceral fat in HIV-associated lipodystrophy.
Mechanism of action
Stabilized GHRH(1-44) analog stimulating endogenous GH secretion.
Short plasma half-life but downstream GH/IGF-1 effects persist longer.
References
Track Tesamorelin for free
Log your doses and PeptideBuddy models Tesamorelin's half-life into a live chart so you always know how much is active — plus reminders, reconstitution and protocol planning.
Start tracking freeFree. No card required.